Target intelligence / Profile preview

Aromatic mutagens

Molecular classification
Other (Chemical Mutagens), Carcinogens
01

Overview

Aromatic mutagens are a broad class of chemical compounds, including polycyclic aromatic hydrocarbons (PAHs) and heterocyclic aromatic amines (HAAs), known for their ability to induce genetic mutations and promote carcinogenesis (IARC, 2010). These substances are common environmental pollutants found in tobacco smoke, industrial emissions, and charred foods (PubChem, 2024). Biologically, most aromatic mutagens are pro-carcinogens that require metabolic activation by Phase I enzymes, such as Cytochrome P450 1A1 (CYP1A1), to become reactive electrophiles (Nebert & Dalton, 2006). Once activated, they can form bulky covalent DNA adducts or intercalate between base pairs, leading to permanent mutations during DNA replication (Xue & Warshawsky, 2005). While they are not therapeutic targets in the traditional sense, they interact significantly with the Aryl hydrocarbon receptor (AhR), which mediates the cellular response to environmental toxins (Denison & Nagy, 2003). Understanding these molecules is critical for developing chemopreventive strategies that aim to inhibit metabolic activation or enhance detoxification pathways like those involving Glutathione S-transferases (Shimada, 2006).

Other names
Polycyclic aromatic hydrocarbonsPAHsHeterocyclic aromatic aminesHAAsArylaminesNitroarenesGenotoxic aromatics
02

Mechanism of action

Chemopreventive agents act by inhibiting Cytochrome P450-mediated metabolic activation and inducing Phase II detoxification enzymes to facilitate the excretion of aromatic mutagens.

03

Biological functions

Other (DNA adduct formation)Other (Mutagenesis)Aryl hydrocarbon receptor activationMetabolic activation
04

Disease associations

CancerOther (Genotoxicity)Other (Teratogenicity)
05

Safety considerations

CarcinogenicityGenotoxicityEnvironmental persistenceBioaccumulation
06

Interacting drugs

Sulforaphane

4 more in the full profile.

07

Biomarkers

DNA adducts (e.g., BPDE-dG)1-hydroxypyreneUrinary mutagenicityMicronuclei induction

Beyond the preview

Go deeper on Aromatic mutagens.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aromatic mutagens.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call